CDH5 and breast cancer: The levels of CD144-EVs (Fig 3A) demonstrated significantly higher levels in both subgroups of BC and CC BT (BCI, CCI) and at the end of standard chemotherapy treatment (BCII, CCII) than in their relative healthy control (HC) groups, correspondingly.